These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 8036552)
1. [IgA serology in idiopathic IgA deposit nephropathy in children]. Coppo R; Amore A; Gianoglio B; Porcellini MG; Peruzzi L; Reyna A; Gusmano R; Giani M; Sereni F; Gianviti A Minerva Urol Nefrol; 1994 Mar; 46(1):49-54. PubMed ID: 8036552 [TBL] [Abstract][Full Text] [Related]
2. Macromolecular IgA and abnormal IgA reactivity in sera from children with IgA nephropathy. Italian Collaborative Paediatric IgA Nephropathy Study. Coppo R; Amore A; Gianoglio B; Porcellini MG; Peruzzi L; Gusmano R; Giani M; Sereni F; Gianviti A; Rizzoni G Clin Nephrol; 1995 Jan; 43(1):1-13. PubMed ID: 7697930 [TBL] [Abstract][Full Text] [Related]
3. IgA serology in recurrent and non-recurrent IgA nephropathy after renal transplantation. Coppo R; Amore A; Cirina P; Messina M; Basolo B; Segoloni G; Berthoux F; Boulharouz R; Egido J; Alcazar R Nephrol Dial Transplant; 1995 Dec; 10(12):2310-5. PubMed ID: 8808231 [TBL] [Abstract][Full Text] [Related]
4. Functional consequences of the binding of gliadin to cultured rat mesangial cells: bridging immunoglobulin A to cells and modulation of eicosanoid synthesis and altered cytokine production. Amore A; Emancipator SN; Roccatello D; Gianoglio B; Peruzzi L; Porcellini MG; Piccoli G; Coppo R Am J Kidney Dis; 1994 Feb; 23(2):290-301. PubMed ID: 8311090 [TBL] [Abstract][Full Text] [Related]
5. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells. Wang Y; Zhao MH; Zhang YK; Li XM; Wang HY Clin Exp Immunol; 2004 Apr; 136(1):168-75. PubMed ID: 15030528 [TBL] [Abstract][Full Text] [Related]
6. Differential effects of circulating IgA isolated from patients with IgA nephropathy on superoxide and fibronectin production of mesangial cells. Chen HC; Guh JY; Chang JM; Lai YH Nephron; 2001 Jul; 88(3):211-7. PubMed ID: 11423751 [TBL] [Abstract][Full Text] [Related]
7. [Serum IgA-fibronectin complex in children with various renal diseases]. Sakai Y; Inaba S; Matsukura H; Okada T Nihon Jinzo Gakkai Shi; 1994 Oct; 36(10):1130-6. PubMed ID: 7815745 [TBL] [Abstract][Full Text] [Related]
8. Role of macromolecular IgA in IgA nephropathy. van der Boog PJ; van Kooten C; de Fijter JW; Daha MR Kidney Int; 2005 Mar; 67(3):813-21. PubMed ID: 15698421 [TBL] [Abstract][Full Text] [Related]
9. Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1. Ebefors K; Liu P; Lassén E; Elvin J; Candemark E; Levan K; Haraldsson B; Nyström J BMC Nephrol; 2016 Apr; 17():40. PubMed ID: 27044423 [TBL] [Abstract][Full Text] [Related]
10. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases. Tissandié E; Morelle W; Berthelot L; Vrtovsnik F; Daugas E; Walker F; Lebrec D; Trawalé JM; Francoz C; Durand F; Moura IC; Paradis V; Moreau R; Monteiro RC Kidney Int; 2011 Dec; 80(12):1352-63. PubMed ID: 21866091 [TBL] [Abstract][Full Text] [Related]
12. Phosphatidylethanolamine binding protein-4 (PEBP4) is increased in IgA nephropathy and is associated with IgA-positive B-cells in affected kidneys. Taylor S; Pieri K; Nanni P; Tica J; Barratt J; Didangelos A J Autoimmun; 2019 Dec; 105():102309. PubMed ID: 31402200 [TBL] [Abstract][Full Text] [Related]
13. A pathogenic role for secretory IgA in IgA nephropathy. Oortwijn BD; van der Boog PJ; Roos A; van der Geest RN; de Fijter JW; Daha MR; van Kooten C Kidney Int; 2006 Apr; 69(7):1131-8. PubMed ID: 16395264 [TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of IgA nephropathy: in vitro activation of human mesangial cells by IgA immune complex leads to cytokine secretion. Chen A; Chen WP; Sheu LF; Lin CY J Pathol; 1994 Jun; 173(2):119-26. PubMed ID: 8089806 [TBL] [Abstract][Full Text] [Related]
15. New insights in the pathogenesis of IgA nephropathy. Monteiro RC Nefrologia; 2005; 25 Suppl 2():82-6. PubMed ID: 16050408 [TBL] [Abstract][Full Text] [Related]
16. IgA-containing immune complexes in the urine of IgA nephropathy patients. Matousovic K; Novak J; Yanagihara T; Tomana M; Moldoveanu Z; Kulhavy R; Julian BA; Konecny K; Mestecky J Nephrol Dial Transplant; 2006 Sep; 21(9):2478-84. PubMed ID: 16757497 [TBL] [Abstract][Full Text] [Related]
17. Patients with IgA nephropathy respond strongly through production of IgA with low avidity against Staphylococcus aureus. Shimizu Y; Seki M; Kaneko S; Hagiwara M; Yoh K; Yamagata K; Koyama A Contrib Nephrol; 2007; 157():139-43. PubMed ID: 17495452 [TBL] [Abstract][Full Text] [Related]
18. Morphometric comparison of the density of the mesangial deposits in idiopathic IgA-nephropathy and Schoenlein-Henoch nephritis. An ultrastructural study. Danilewicz M; Wagrowska-Danilewicz M Rocz Akad Med Bialymst; 1997; 42 Suppl 2():7-11. PubMed ID: 9646676 [TBL] [Abstract][Full Text] [Related]
19. IgA antigliadin antibodies in children with IgA mesangial glomerulonephritis. Rodriguez-Soriano J; Arrieta A; Vallo A; Sebastian MJ; Vitoria JC; Masdevall MD Lancet; 1988 May; 1(8594):1109-10. PubMed ID: 2896938 [No Abstract] [Full Text] [Related]
20. IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells. Novak J; Raskova Kafkova L; Suzuki H; Tomana M; Matousovic K; Brown R; Hall S; Sanders JT; Eison TM; Moldoveanu Z; Novak L; Novak Z; Mayne R; Julian BA; Mestecky J; Wyatt RJ Nephrol Dial Transplant; 2011 Nov; 26(11):3451-7. PubMed ID: 21828345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]